Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting
- Aluwini, S.S.
- Mehra, N.
- Lolkema, M.P.
- Oprea-Lager, D.E.
- Yakar, D.
- Stoevelaar, H.
- Poel, H.G. van der
- Busstra, M.
- Jong, I.J. de
- Reijke, T. de
- Vries, K. de
- Heijmink, S.
- Jenster, G.
- Klaver, S.
- Kneppers, J.
- Lavalaye, J.
- Leyten, G.
- Moonen, L.
- Nagaraj, J.
- Noordzij, W.
- Osanto, S.
- Oving, I.
- Schaake, E.
- Scheenen, T.W.J.
- Schoots, I.
- Sedelaar, M.
- Somford, D.M.
- Berkmortel, F.W. van den
- Hulle, T. van der
- Voort van Zyp, J.R.N. van der
- Leeuwen, P. van
- Moorselaar, J. van
- Oort, I.M. van
- Vogel, W.
- Westgeest, H.
DOIAbstract
BACKGROUND: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state that is imperfectly understood, and its clinical implications are unclear. OBJECTIVE: To determine the consensus of a Dutch multidisciplinary expert panel on biological aspects, treatment goals, and management of OMPC in daily clinical practice. DESIGN, SETTING, AND PARTICIPANTS: The study comprised a modified Delphi method including an explorative survey with various statements and questions, followed by a consensus meeting to discuss and determine the agreement with revised statements and related items. The panel consisted of 34 Dutch representatives from urology, medical and radiation oncology, radiology, nuclear medicine, and basic research. OUTCOME MEAS...
Add to ORKG